Speaker illustration

Mrs Saga Itainen-Stromberg

Helsinki University Hospital, Helsinki (Finland)

Member of:

European Society of Cardiology

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Event: ESC Congress 2022

Topic: Rhythm Control, Cardioversion

Session: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Thumbnail

Oral anticoagulation in patients undergoing elective cardioversion of atrial fibrillation. Real-life experience from Finland

Event: ESC Congress 2019

Topic: Rhythm Control, Cardioversion

Session: Drug treatment for atrial fibrillation

Thumbnail

Direct oral anticoagulants in atrial fibrillation patients undergoing cardioversion. Nationwide multicentre study.

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: New trends in antithrombotic therapy for atrial fibrillation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb